Healthcare & Pharma

With one of the vast network of life sciences professionals and clientele ranging from research scientists to pharmaceutical companies and hospitals, Areness led by one of its top management hailing from a biomedicine background has a keen affinity towards this sector. Patents to licensing, protection from regulatory action to international trade, we provide end to end support to the said sector.

Understanding the demands of the sector, we guide through the process of mandatory approvals from various statutory authorities and also protect the intellectual property globally. We also assist in licensing, leasing, labelling and other compliances. We guide our clients through reporting of new guidelines, taking safety measures to avoid regulatory action and work with intermediaries for extensive coverage.

Opinions

DATA PROTECTION REGULATIONS FOR THE START-UP SECTOR IN INDIA: IMPLICATIONS AND POLICY MEASURES

Read Me

You Tube’s Terms of Use: Playing the Brands’ Band

Read Me

Difference between Wilful Defaulters and NPA under section 29A of IBC, 2016

Read Me

Research and Insights

Cross Border Insolvency under the I & B Code, 2016: The road ahead

Law relating to cross border insolvency concerns itself with Indian financial creditors having claims upon defaulting companies which are global, or global financial persons having claims

Download

Arcelormittal India Private Limited Vs. Satish Kumar Gupta & Ors.: Filling of Judicial Granite in 29A(c) of Insolvency & Bankruptcy Code, 2016

‘Quando aliquid prohibetur ex directo, prohibetur et per obliquum’, meaning what cannot be done directly, cannot be done indirectly,

Download

SALE AS A GOING CONCERN UNDER LIQUIDATION: A SAFTEY TOOL

The enactment of the Insolvency & Bankruptcy Code, 2016 (‘Code’) introduced a revamped regime for the liquidation of companies for which insolvency resolution has failed.

Download
Area Of Practice

Other Practice Areas